Chronic obstructive pulmonary disease. (©2012)
- Record Type:
- Book
- Title:
- Chronic obstructive pulmonary disease. (©2012)
- Main Title:
- Chronic obstructive pulmonary disease
- Further Information:
- Note: Guest editors, Stephen I. Rennard, Bartolome R. Celli.
- Other Names:
- Rennard, Stephen I, 1954-
Celli, Bartolome R - Contents:
- Front Cover; Medical Clinics of North America; Copyright Page; Contributors; Table of Contents; Preface; Chapter 1. Chronic Obstructive Pulmonary Disease: A Worldwide Problem; EPIDEMIOLOGY; DEFINITION OF COPD; RISK FACTORS; SPIROMETRY SCREENING; BURDEN OF COPD IN DEVELOPING COUNTRIES; FUTURE; ACKNOWLEDGMENTS; REFERENCES; Chapter 2. Pathobiologic Mechanisms of Chronic Obstructive Pulmonary Disease; INTRODUCTION; PHENOTYPES OF COPD; PROPERTIES OF CS; CYTOCHROME P-450 GENE EXPRESSION; PATHOBIOLOGIC MECHANISMS; DUTCH, BRITISH, AND AMERICAN HYPOTHESES; PROTEASE-ANTIPROTEASE HYPOTHESIS OF EMPHYSEMA. AUTOIMMUNE HYPOTHESIS OF COPDGWAS AND COPD; SUMMARY; REFERENCES; Chapter 3. Genes and Chronic Obstructive Pulmonary Disease; COPD DUE TO SEVERE AAT DEFICIENCY; GENETICS OF COPD UNRELATED TO SEVERE AAT DEFICIENCY; SUMMARY; REFERENCES; Chapter 4. Contribution of the Environment and Comorbidities to Chronic Obstructive Pulmonary Disease Phenotypes; ENVIRONMENT; HOST FACTORS; COMORBIDITIES; PROGRESS IN DISEASE PHENOTYPES; SUMMARY; REFERENCES; Chapter 5. The Role and Potential of Imaging in COPD; INTRODUCTION; CT; MRI; PET; OCT; REFERENCES. Chapter 6. The Importance of the Assessment of Pulmonary Function in COPDINTRODUCTION; ROLE OF SPIROMETRY IN THE DIAGNOSIS OF COPD; INTRODUCTION TO PULMONARY FUNCTION TESTING; DIAGNOSIS OF COPD BASED ON SPIROMETRY; DIFFERENTIATING COPD FROM ASTHMA WITH BRONCHODILATOR REVERSIBILITY TESTING; QUANTIFYING COPD SEVERITY WITH SPIROMETRY; ROLE OF SPIROMETRY INFront Cover; Medical Clinics of North America; Copyright Page; Contributors; Table of Contents; Preface; Chapter 1. Chronic Obstructive Pulmonary Disease: A Worldwide Problem; EPIDEMIOLOGY; DEFINITION OF COPD; RISK FACTORS; SPIROMETRY SCREENING; BURDEN OF COPD IN DEVELOPING COUNTRIES; FUTURE; ACKNOWLEDGMENTS; REFERENCES; Chapter 2. Pathobiologic Mechanisms of Chronic Obstructive Pulmonary Disease; INTRODUCTION; PHENOTYPES OF COPD; PROPERTIES OF CS; CYTOCHROME P-450 GENE EXPRESSION; PATHOBIOLOGIC MECHANISMS; DUTCH, BRITISH, AND AMERICAN HYPOTHESES; PROTEASE-ANTIPROTEASE HYPOTHESIS OF EMPHYSEMA. AUTOIMMUNE HYPOTHESIS OF COPDGWAS AND COPD; SUMMARY; REFERENCES; Chapter 3. Genes and Chronic Obstructive Pulmonary Disease; COPD DUE TO SEVERE AAT DEFICIENCY; GENETICS OF COPD UNRELATED TO SEVERE AAT DEFICIENCY; SUMMARY; REFERENCES; Chapter 4. Contribution of the Environment and Comorbidities to Chronic Obstructive Pulmonary Disease Phenotypes; ENVIRONMENT; HOST FACTORS; COMORBIDITIES; PROGRESS IN DISEASE PHENOTYPES; SUMMARY; REFERENCES; Chapter 5. The Role and Potential of Imaging in COPD; INTRODUCTION; CT; MRI; PET; OCT; REFERENCES. Chapter 6. The Importance of the Assessment of Pulmonary Function in COPDINTRODUCTION; ROLE OF SPIROMETRY IN THE DIAGNOSIS OF COPD; INTRODUCTION TO PULMONARY FUNCTION TESTING; DIAGNOSIS OF COPD BASED ON SPIROMETRY; DIFFERENTIATING COPD FROM ASTHMA WITH BRONCHODILATOR REVERSIBILITY TESTING; QUANTIFYING COPD SEVERITY WITH SPIROMETRY; ROLE OF SPIROMETRY IN THE MANAGEMENT OF COPD; SUMMARY; REFERENCES; Chapter 7. Role of Exercise in Testing and in Therapy of COPD; INTRODUCTION; MODALITIES OF EXERCISE TESTING; SUMMARY; REFERENCES. Chapter 8. Defining Patient-Reported Outcomes in Chronic Obstructive Pulmonary Disease: The Patient-Centered ExperienceINTRODUCTION; DEFINING THE PATIENT EXPERIENCE AND PATIENT-REPORTED OUTCOMES; DEFINING AND MEASURING HRQOL; ACCOUNTING FOR PATIENT PREFERENCES; INTERPRETING HRQOL MEASURES; PREDICTIVE MODELS; HRQOL IN COPD; ASSOCIATIONS OF PROs WITH PHYSIOLOGIC MEASURES; THE IMPACT OF COPD ON PROs; INTERVENTIONS THAT AFFECT HRQOL; SUMMARY; REFERENCES; Chapter 9. COPD Exacerbations: Causes, Prevention, and Treatment; FREQUENT EXACERBATOR PHENOTYPE; VIRAL INFECTIONS; BACTERIAL INFECTIONS. ENVIRONMENTAL FACTORSEXACERBATION PREVENTION; PHARMACOLOGIC THERAPIES; NONPHARMACOLOGIC THERAPIES; SUMMARY; REFERENCES; Chapter 10. An Integrated Approach to the Medical Treatment of Chronic Obstructive Pulmonary Disease; INTRODUCTION; EVALUATING COPD SEVERITY IN CLINICAL PRACTICE: MORE THAN THE FORCED EXPIRATORY VOLUME IN THE FIRST SECOND OF EXPIRATION; COPD MEDICAL THERAPY IN CONTEXT; SUMMARY; REFERENCES; Chapter 11. Medical Pneumoplasty, Surgical Resection, or Lung Transplant; INTRODUCTION; PATHOPHYSIOLOGIC BASIS FOR LUNG VOLUME REDUCTION; MEDICAL PNEUMOPLASTY; SURGICAL RESECTION; SUMMARY. … (more)
- Publisher Details:
- Philadelphia : Saunders
- Publication Date:
- 2012
- Copyright Date:
- 2012
- Extent:
- 1 online resource (xii, pages 671-880), illustrations (some color)
- Subjects:
- 616.24
Lungs -- Diseases, Obstructive
Lungs -- Diseases, Obstructive -- Treatment
MEDICAL -- Pulmonary & Thoracic Medicine
Lungs -- Diseases, Obstructive
Lungs -- Diseases, Obstructive -- Treatment
Electronic books - Languages:
- English
- ISBNs:
- 9781455742936
1455742937 - Related ISBNs:
- 9781455738908
- Notes:
- Note: Includes bibliographical references and index.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.240015
- Ingest File:
- 01_156.xml